Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Immunol. 2022 Aug 11;13:954744. doi: 10.3389/fimmu.2022.954744. eCollection 2022.
Fra-1(Fos-related antigen1), a member of transcription factor activator protein (AP-1), plays an important role in cell proliferation, apoptosis, differentiation, inflammation, oncogenesis and tumor metastasis. Accumulating evidence suggest that the malignancy and invasive ability of tumors can be significantly changed by directly targeting Fra-1. Besides, the effects of Fra-1 are gradually revealed in immune and inflammatory settings, such as arthritis, pneumonia, psoriasis and cardiovascular disease. These regulatory mechanisms that orchestrate immune and non-immune cells underlie Fra-1 as a potential therapeutic target for a variety of human diseases. In this review, we focus on the current knowledge of Fra-1 in immune system, highlighting its unique importance in regulating tissue homeostasis. In addition, we also discuss the possible critical intervention strategy in diseases, which also outline future research and development avenues.
Fra-1(Fos 相关抗原 1)是转录因子激活蛋白(AP-1)家族的成员,在细胞增殖、凋亡、分化、炎症、肿瘤发生和转移中发挥重要作用。越来越多的证据表明,直接靶向 Fra-1 可以显著改变肿瘤的恶性程度和侵袭能力。此外,Fra-1 在免疫和炎症环境中的作用逐渐显现,如关节炎、肺炎、银屑病和心血管疾病。这些调节免疫和非免疫细胞的调控机制使 Fra-1 成为多种人类疾病的潜在治疗靶点。在这篇综述中,我们重点介绍 Fra-1 在免疫系统中的最新知识,强调其在调节组织稳态方面的独特重要性。此外,我们还讨论了在疾病中可能的关键干预策略,为未来的研究和发展指明了方向。